Stability indicating thin-layer chromatographic method for estimation of antidiabetic drug Remogliflozin etabonate

Abstract Background A sensitive, precise, and stability-indicating high-performance thin-layer chromatographic (HPTLC) method has been developed for the analysis of Remogliflozin etabonate in tablet formulation. HPTLC plates precoated with silica gel 60 F254 were used as the stationary phase; methan...

Full description

Bibliographic Details
Main Authors: Dimal A. Shah, Ishita I. Gondalia, Vandana B. Patel, Ashok Mahajan, Usmangani Chhalotiya, Dhruti C. Nagda
Format: Article
Language:English
Published: SpringerOpen 2021-04-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
Online Access:https://doi.org/10.1186/s43094-021-00230-6
id doaj-4b4885d94ec74cb2a1a4dce507f04253
record_format Article
spelling doaj-4b4885d94ec74cb2a1a4dce507f042532021-04-11T11:38:58ZengSpringerOpenFuture Journal of Pharmaceutical Sciences2314-72532021-04-017111210.1186/s43094-021-00230-6Stability indicating thin-layer chromatographic method for estimation of antidiabetic drug Remogliflozin etabonateDimal A. Shah0Ishita I. Gondalia1Vandana B. Patel2Ashok Mahajan3Usmangani Chhalotiya4Dhruti C. Nagda5Babaria Institute of Pharmacy, BITS Edu CampusBabaria Institute of Pharmacy, BITS Edu CampusBabaria Institute of Pharmacy, BITS Edu CampusBabaria Institute of Pharmacy, BITS Edu CampusIndukaka Ipcowala College of PharmacyA. R. College of PharmacyAbstract Background A sensitive, precise, and stability-indicating high-performance thin-layer chromatographic (HPTLC) method has been developed for the analysis of Remogliflozin etabonate in tablet formulation. HPTLC plates precoated with silica gel 60 F254 were used as the stationary phase; methanol: ethyl acetate: toluene: NH3 (2:4:4:0.1, v/v/v) was used as mobile phase, and densitometry was used for the quantitative estimation of the drug. The proposed method was validated with respect to linearity, accuracy, precision, and robustness and applied for the estimation of drug in tablet dosage form. Results The R f value of Remogliflozin etabonate was observed to be 0.61. The densitometric estimation was performed in reflectance mode at 229 nm. The method was found to be linear in the range of 500–8000 ng/band for Remogliflozin etabonate. The possible degradation pathway was estimated by performing forced degradation studies. The degradant peaks were well resolved from the drug peak with acceptable resolution in their R f value. Conclusion An accurate and precise high-performance thin-layer chromatographic method has been developed for the quantification of Remogliflozin etabonate in tablets. Forced degradation studies were performed, and drug was found to be highly susceptible to acid, base hydrolysis, and oxidative stress degradation and gets converted into active drug Remogliflozin. Both Remogliflozin etabonate and Remogliflozin bands were well resolved. The method was applied for the analysis of drug in tablet formulation, and it can be used for routine quality control analysis, as well as for the analysis of stability samples.https://doi.org/10.1186/s43094-021-00230-6Remogliflozin etabonateHPTLCValidationForced degradation studies
collection DOAJ
language English
format Article
sources DOAJ
author Dimal A. Shah
Ishita I. Gondalia
Vandana B. Patel
Ashok Mahajan
Usmangani Chhalotiya
Dhruti C. Nagda
spellingShingle Dimal A. Shah
Ishita I. Gondalia
Vandana B. Patel
Ashok Mahajan
Usmangani Chhalotiya
Dhruti C. Nagda
Stability indicating thin-layer chromatographic method for estimation of antidiabetic drug Remogliflozin etabonate
Future Journal of Pharmaceutical Sciences
Remogliflozin etabonate
HPTLC
Validation
Forced degradation studies
author_facet Dimal A. Shah
Ishita I. Gondalia
Vandana B. Patel
Ashok Mahajan
Usmangani Chhalotiya
Dhruti C. Nagda
author_sort Dimal A. Shah
title Stability indicating thin-layer chromatographic method for estimation of antidiabetic drug Remogliflozin etabonate
title_short Stability indicating thin-layer chromatographic method for estimation of antidiabetic drug Remogliflozin etabonate
title_full Stability indicating thin-layer chromatographic method for estimation of antidiabetic drug Remogliflozin etabonate
title_fullStr Stability indicating thin-layer chromatographic method for estimation of antidiabetic drug Remogliflozin etabonate
title_full_unstemmed Stability indicating thin-layer chromatographic method for estimation of antidiabetic drug Remogliflozin etabonate
title_sort stability indicating thin-layer chromatographic method for estimation of antidiabetic drug remogliflozin etabonate
publisher SpringerOpen
series Future Journal of Pharmaceutical Sciences
issn 2314-7253
publishDate 2021-04-01
description Abstract Background A sensitive, precise, and stability-indicating high-performance thin-layer chromatographic (HPTLC) method has been developed for the analysis of Remogliflozin etabonate in tablet formulation. HPTLC plates precoated with silica gel 60 F254 were used as the stationary phase; methanol: ethyl acetate: toluene: NH3 (2:4:4:0.1, v/v/v) was used as mobile phase, and densitometry was used for the quantitative estimation of the drug. The proposed method was validated with respect to linearity, accuracy, precision, and robustness and applied for the estimation of drug in tablet dosage form. Results The R f value of Remogliflozin etabonate was observed to be 0.61. The densitometric estimation was performed in reflectance mode at 229 nm. The method was found to be linear in the range of 500–8000 ng/band for Remogliflozin etabonate. The possible degradation pathway was estimated by performing forced degradation studies. The degradant peaks were well resolved from the drug peak with acceptable resolution in their R f value. Conclusion An accurate and precise high-performance thin-layer chromatographic method has been developed for the quantification of Remogliflozin etabonate in tablets. Forced degradation studies were performed, and drug was found to be highly susceptible to acid, base hydrolysis, and oxidative stress degradation and gets converted into active drug Remogliflozin. Both Remogliflozin etabonate and Remogliflozin bands were well resolved. The method was applied for the analysis of drug in tablet formulation, and it can be used for routine quality control analysis, as well as for the analysis of stability samples.
topic Remogliflozin etabonate
HPTLC
Validation
Forced degradation studies
url https://doi.org/10.1186/s43094-021-00230-6
work_keys_str_mv AT dimalashah stabilityindicatingthinlayerchromatographicmethodforestimationofantidiabeticdrugremogliflozinetabonate
AT ishitaigondalia stabilityindicatingthinlayerchromatographicmethodforestimationofantidiabeticdrugremogliflozinetabonate
AT vandanabpatel stabilityindicatingthinlayerchromatographicmethodforestimationofantidiabeticdrugremogliflozinetabonate
AT ashokmahajan stabilityindicatingthinlayerchromatographicmethodforestimationofantidiabeticdrugremogliflozinetabonate
AT usmanganichhalotiya stabilityindicatingthinlayerchromatographicmethodforestimationofantidiabeticdrugremogliflozinetabonate
AT dhruticnagda stabilityindicatingthinlayerchromatographicmethodforestimationofantidiabeticdrugremogliflozinetabonate
_version_ 1721530793186033664